Skip navigation

Calls to Action

Delsia

Investors, Entrepreneurs Gather for Second Annual Autism Speaks Autism Investment Conference

Event highlights innovative services, technology and product development to address the unmet needs of the autism community

Researchers, entrepreneurs, investors, executives, healthcare professionals and autism-service providers gather in San Francisco

March 06, 2014

San Francisco, Calif. (March 6, 2014) – This week, Autism Speaks welcomed more than 150 researchers, entrepreneurs, investors, biotech and pharmaceutical executives, healthcare professionals and autism-service providers to its second annual Autism Investment Conference (AIC) in San Francisco.

Google Brings Entrepreneurial Boot Camp to Autism Investment Conference

Attendees to Autism Speaks business conference invited to complementary day-long workshop at Googleplex
January 14, 2014

This year’s Autism Investment Conference just became more exciting and cutting edge. Autism Speaks’ partner Google Inc. is offering a complementary, day-long “Equipping Entrepreneurs” workshop for all registrants.

Autism Speaks Hosts World’s First Autism Investment Conference

February 22, 2013

On February 21st, investors and product developers came together to discuss opportunities for addressing the autism community’s unmet needs

 

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

DELSIA’s First Award funded by Autism Speaks Supports Development of Arbaclofen and other Innovative Treatments for ASD

Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership be

December 03, 2012

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to discover biomarkers that can be used to facilitate the development of safe, effective and personalized treatments of autism spectrum disorders (ASD).